Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody

Lymphocytic Leukemia ◽

Ccr7 Expression ◽

Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia, a novel therapeutic anti-CCR7 antibody.

IBJ Plus ◽

10.24217/2531-0151.21v1s4.00040 ◽

2021 ◽

Author(s):

◽

...

Keyword(s):

Lymphocytic Leukemia ◽

Ccr7 Expression ◽

Abstract 3073: Targeting chronic lymphocytic leukemia by interfering glutathione synthesis using a novel therapeutic enzyme cyst(e)inase (AEB3103)

10.1158/1538-7445.am2016-3073 ◽

2016 ◽

Author(s):

Jinyun Liu ◽

Li Feng ◽

Everett M. Stone ◽

Joseph Tyler ◽

Scott W. Rowlinson ◽

...

Keyword(s):

Lymphocytic Leukemia ◽

Glutathione Synthesis ◽

Immune dysfunction complexity in chronic lymphocytic leukemia ‒ an issue to consider when designing novel therapeutic strategies

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1755857 ◽

2020 ◽

Vol 61 (9) ◽

pp. 2050-2058

Author(s):

Shimrit Ringelstein-Harlev

Keyword(s):

Immune Dysfunction ◽

Therapeutic Strategies ◽

Lymphocytic Leukemia ◽

Novel Therapeutic Strategies ◽

Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia

Leukemia ◽

10.1038/leu.2010.220 ◽

2010 ◽

Vol 24 (12) ◽

pp. 2122-2127 ◽

Cited By ~ 3

Author(s):

M Shehata ◽

D Demirtas ◽

S Schnabl ◽

M Hilgarth ◽

R Hubmann ◽

...

Keyword(s):

Gene Expression ◽

Gene Expression Profiling ◽

Expression Profiling ◽

Therapeutic Targets ◽

Predictive Markers ◽

Lymphocytic Leukemia ◽

Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches

Leukemia & Lymphoma ◽

10.3109/10428194.2011.610014 ◽

2012 ◽

Vol 53 (4) ◽

pp. 537-549 ◽

Cited By ~ 16

Author(s):

Rachel E. Hayden ◽

Guy Pratt ◽

Claudia Roberts ◽

Mark T. Drayson ◽

Chris M. Bunce

Keyword(s):

Lymph Node ◽

Lymphocytic Leukemia ◽

Therapeutic Approaches ◽

Cell death induction of chronic lymphocytic leukemia lymphocytes using VDAC1-based peptides: A novel therapeutic approach

Biochimica et Biophysica Acta (BBA) - Bioenergetics ◽

10.1016/j.bbabio.2010.04.221 ◽

2010 ◽

Vol 1797 ◽

pp. 68-69

Author(s):

Tal Prezma ◽

Ziv Raviv ◽

Itai Levi ◽

Varda Shoshan-Barmatz

Keyword(s):

Cell Death ◽

Therapeutic Approach ◽

Lymphocytic Leukemia ◽

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

Haematologica ◽

10.3324/haematol.2016.148965 ◽

2017 ◽

Vol 102 (5) ◽

pp. 874-882 ◽

Cited By ~ 22

Author(s):

Mika Shapiro ◽

Yair Herishanu ◽

Ben-Zion Katz ◽

Nili Dezorella ◽

Clare Sun ◽

...

Keyword(s):

Therapeutic Target ◽

Lymphocyte Activation ◽

Lymphocytic Leukemia ◽

Lymphocyte Activation Gene ◽

Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options

Cancer Letters ◽

10.1016/j.canlet.2012.08.012 ◽

2013 ◽

Vol 328 (1) ◽

pp. 27-35 ◽

Cited By ~ 12

Author(s):

Valentina Audrito ◽

Tiziana Vaisitti ◽

Sara Serra ◽

Cinzia Bologna ◽

Davide Brusa ◽

...

Keyword(s):

Lymphocytic Leukemia ◽

Therapeutic Options ◽

Novel Therapeutic Strategies With Alemtuzumab for Chronic Lymphocytic Leukemia

Seminars in Oncology ◽

10.1053/j.seminoncol.2006.01.025 ◽

2006 ◽

Vol 33 ◽

pp. 15-22 ◽

Cited By ~ 7

Author(s):

Kanti R. Rai

Keyword(s):

Therapeutic Strategies ◽

Lymphocytic Leukemia ◽

Novel Therapeutic Strategies ◽

Abstract A187: Matrix metalloproteinase-9 as a novel therapeutic target in B-cell chronic lymphocytic leukemia.

10.1158/1535-7163.targ-13-a187 ◽

2013 ◽

Author(s):

Elvira Bailón ◽

Estefanía Ugarte-Berzal ◽

Irene Amigo-Jiménez ◽

Philippe Van den Steen ◽

Ghislain Opdenakker ◽

...

Keyword(s):

Matrix Metalloproteinase ◽

B Cell ◽

Therapeutic Target ◽

Matrix Metalloproteinase 9 ◽

Lymphocytic Leukemia ◽

Metalloproteinase 9 ◽

Cell Chronic Lymphocytic Leukemia ◽